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Introduction 
 
It is well recognized that dietary isoflavones require the action of components of the intestinal 
microbiota for transformation and activation (Crozier et al., 2009; Kemperman et al., 2010). 
On the other hand, as polyphenolics, isoflavones may also have an inhibitory effect on certain 
intestinal microbial groups. Identifying the microbial species involved in isoflavone 
activation and metabolism will help in designing strategies aimed to increase desirable 
populations, enhancing isoflavone activation and minimizing isoflavone degradation. Little is 
also known on the evolution of metabolic markers of (intestinal) health during isoflavone 
interventions. These aspects are critical for understanding the mechanisms through which 
their intake has beneficial effects in menopause symptoms (Bolaños et al., 2010; Messina, 
2010) and other diseases (Virk-Baker et al., 2010; Bhupathy et al., 2010). 
In this study, we evaluated the effect of isoflavones on faecal microbiota composition of 18 
climacteric women receiving a daily treatment for six months with a dietary supplement rich 
in soy isoflavones (Fisiogen, Zambon). Identification and quantification of equol, an 
isoflavone metabolite, in urine during the treatment was also monitored. 
 
Material and Methods 
 
The analysis of the microbial populations was conducted using culturing techniques (using 
selective and differential culture media for majority and representative bacterial groups) and 
the culture-independent method of denaturing gradient gel electrophoresis (DGGE). The 
presence of equol in urine, the most estrogenic compound derived from the metabolism of the 
daidzein isoflavone, was scored by an ultra performance liquid chromatography (UPLC) 
method. 
 
Results and Discussion 
 
As shown in Figure 1, culturing microbiological analysis revealed a decrease along the 
treatment on enterobacteria counts in most women. Furthermore, all studied bacterial 
populations of faeces showed a decreasing tendency in some women throughout the 
treatment, while no effect on bacterial population numbers was observed in samples from 
some others.  
Molecular microbial analysis of the faecal populations by the DGGE technique using 
universal primers for the bacterial 16S rRNA gene showed individual and characteristic 
electrophoretic profiles for each woman. Figure 2 shows the DGGE profiles of two different 
individuals. 
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Figure 1. Changes in faecal counts (log 
cfu/g) of some microbial groups after 1, 3 
and 6 months of isoflavone treatment. Key 
of media and bacterial groups: MCB, colonic 
microbiota; MRS, lactic acid bacteria; BIF, 
bifidobacteria; RCM, clostridia; EMB, 
enterobacteria; BP, Bacteroides-Prevotella 
group; and VA; Veillonella. 
 
 
 
Intensification and/or appearance of new bands in some patients during isoflavone intake was 
also observed (Figure 2). Reamplification and sequencing proved these bands to belong to 
species such as Ruminococcus flavefaciens (Figure 2A), Bifidobacterium 
adolescentis/ruminantium (Figure 2B), and Lactonifactor longoviformis (not shown). These 
microorganisms might be favoured somehow by the presence of high levels of isoflavones 
into the gastrointestinal tract. 
 
 
 
 
Figure 2. DGGE profiles of 16S rRNA gene 
amplicons from feacal samples of two different 
women during isoflavone treatment at time 0, and 
after 1, 3 and 6 months of isoflavone intake. 
 
 
 
 
 
 
On the other hand, in most women it appears that the bacterial diversity decreased during 
isoflavone treatment. This reduction in diversity was estimated on the basis of the number of 
bands (assuming to be equivalent to the number of species) and their relative intensity by 
using the index of Shannon-Weaver (H index) (Figure 3). 
 
 
 
Figure 3. Variation of the Shannon diversity index (H 
index) in the DGGE profiles of faecal samples throughout 
the treatment from a volunteer, as calculated using the 
GeneTools software (Syngene). 
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By UPLC, equol was detected in the urine of 12 women. The variation of this compound in 
three of the women during the treatment is depicted in Figure 4. In eight out of the 12 women 
a low and constant equol concentration through the treatment was observed, as shown in the 
figure for Woman 15. However, in four women equol concentration increases significantly in 
urine after isoflavone intake, as compared to the basal levels (see Woman 9 and 26 in Figure 
4). 
 
 
 
Figure 4. Variation in the level of equol in urine 
in three different women during isoflavone 
intake. 
 
 
 
 
 
 
The results suggest that isoflavone intake significantly affects the numbers of some intestinal 
microbial populations and the level of equol in some equol-producing women. These effects 
might ultimately be related to the beneficial health properties of isoflavones consumption. 
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